LT2771357T - Pelės su genetiškai modifikuotu t ląstelių receptoriumi - Google Patents

Pelės su genetiškai modifikuotu t ląstelių receptoriumi

Info

Publication number
LT2771357T
LT2771357T LTEP12784833.1T LT12784833T LT2771357T LT 2771357 T LT2771357 T LT 2771357T LT 12784833 T LT12784833 T LT 12784833T LT 2771357 T LT2771357 T LT 2771357T
Authority
LT
Lithuania
Prior art keywords
genetically modified
cell receptor
receptor mice
mice
cell
Prior art date
Application number
LTEP12784833.1T
Other languages
English (en)
Inventor
Lynn Macdonald
Andrew Murphy
John Mcwhirter
Naxin Tu
Vera VORONINA
Cagan Gurer
Karolina MEAGHER
Sean Stevens
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of LT2771357T publication Critical patent/LT2771357T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
LTEP12784833.1T 2011-10-28 2012-10-26 Pelės su genetiškai modifikuotu t ląstelių receptoriumi LT2771357T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552582P 2011-10-28 2011-10-28
US201261621198P 2012-04-06 2012-04-06
US201261700908P 2012-09-14 2012-09-14
PCT/US2012/062065 WO2013063361A1 (en) 2011-10-28 2012-10-26 Genetically modified t cell receptor mice

Publications (1)

Publication Number Publication Date
LT2771357T true LT2771357T (lt) 2018-10-25

Family

ID=47178340

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP12784833.1T LT2771357T (lt) 2011-10-28 2012-10-26 Pelės su genetiškai modifikuotu t ląstelių receptoriumi
LTEP18176096.8T LT3424947T (lt) 2011-10-28 2012-10-26 Genetiškai modifikuotos t ląstelių receptorių pelės

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTEP18176096.8T LT3424947T (lt) 2011-10-28 2012-10-26 Genetiškai modifikuotos t ląstelių receptorių pelės

Country Status (25)

Country Link
US (4) US9113616B2 (lt)
EP (3) EP2771357B1 (lt)
JP (7) JP6254528B2 (lt)
KR (5) KR102148387B1 (lt)
CN (5) CN107858332A (lt)
AU (4) AU2012327204B2 (lt)
BR (1) BR112014009203B1 (lt)
CA (1) CA2853707A1 (lt)
CY (2) CY1120945T1 (lt)
DK (2) DK2771357T3 (lt)
ES (2) ES2858978T3 (lt)
HK (1) HK1198171A1 (lt)
HR (2) HRP20181626T1 (lt)
HU (1) HUE053444T2 (lt)
IL (3) IL305550A (lt)
IN (1) IN2014CN03890A (lt)
LT (2) LT2771357T (lt)
MX (1) MX353134B (lt)
PL (2) PL3424947T3 (lt)
PT (2) PT2771357T (lt)
RS (2) RS57893B1 (lt)
RU (1) RU2661106C2 (lt)
SG (2) SG10201914043XA (lt)
SI (2) SI3424947T1 (lt)
WO (1) WO2013063361A1 (lt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL305550A (en) * 2011-10-28 2023-10-01 Regeneron Pharma Mice with a genetic change in the T cell receptor
US20150073043A1 (en) * 2012-01-19 2015-03-12 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Use of phosphorylation pathway-related factor in regulating function of regulatory t cell
WO2013163394A1 (en) 2012-04-25 2013-10-31 Regeneron Pharmaceuticals, Inc. Nuclease-mediated targeting with large targeting vectors
GB2508414A (en) * 2012-11-30 2014-06-04 Max Delbrueck Centrum Tumour specific T cell receptors (TCRs)
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
CN111500630A (zh) 2013-04-16 2020-08-07 瑞泽恩制药公司 大鼠基因组的靶向修饰
US9546384B2 (en) 2013-12-11 2017-01-17 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a mouse genome
CN113215196A (zh) 2014-06-06 2021-08-06 瑞泽恩制药公司 用于修饰所靶向基因座的方法和组合物
PT3157956T (pt) * 2014-06-19 2020-04-09 Regeneron Pharma Animais não humanos com um gene 1 de morte programada humanizada em células
HUE041584T2 (hu) 2014-06-26 2019-05-28 Regeneron Pharma Célzott genetikai módosítások és alkalmazási módszerek és készítmények
BR112017005245A2 (pt) 2014-09-19 2017-12-12 Regeneron Pharma animal não humano geneticamente modificado, métodos para produzir célula t, hibridoma de célula t, um ácido nucleico, um anticorpo específico, uma célula humana, um animal não humano geneticamente modificado e para induzir uma resposta imunológica, célula, hibridoma de célula t, ácido nucleico, anticorpo específico, receptor de antígeno quimérico, embrião não humano, locus de um receptor de antígeno quimérico, e, composição de ácidos nucleicos.
PT3221457T (pt) 2014-11-21 2019-06-27 Regeneron Pharma Métodos e composições para modificação genética visada através da utilização de arn guia emparelhados
RS63410B1 (sr) * 2014-11-24 2022-08-31 Regeneron Pharma Ne-humane životinje koje eksprimiraju humanizovani cd3 kompleks
RU2707137C2 (ru) 2014-12-19 2019-11-22 Регенерон Фармасьютикалз, Инк. Способы и композиции для нацеленной генетической модификации посредством одноэтапного множественного нацеливания
RU2732628C2 (ru) * 2015-04-06 2020-09-21 Регенерон Фармасьютикалз, Инк. Опосредованные гуманизированными т-клетками иммунные ответы у не относящихся к человеку животных
KR102138209B1 (ko) 2015-05-06 2020-07-28 스니프르 테크놀로지스 리미티드 미생물 개체군 변경 및 미생물군 변형
US10306874B2 (en) * 2015-11-20 2019-06-04 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
US20190161530A1 (en) * 2016-04-07 2019-05-30 Bluebird Bio, Inc. Chimeric antigen receptor t cell compositions
CR20180531A (es) 2016-04-08 2019-06-13 Immunocore Ltd Receptores de células t
CN116458475A (zh) * 2016-06-03 2023-07-21 瑞泽恩制药公司 表达外源末端脱氧核苷酸转移酶的非人动物
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
EP3638262A4 (en) * 2017-06-16 2021-03-24 Mayo Foundation for Medical Education and Research MATERIALS AND METHODS FOR INCREASING IMMUNE REACTION
WO2019070541A1 (en) 2017-10-03 2019-04-11 Juno Therapeutics, Inc. HPV-SPECIFIC BINDING MOLECULES
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
MA52656A (fr) * 2018-04-05 2021-02-17 Editas Medicine Inc Procédés de production de cellules exprimant un récepteur recombinant et compositions associées
SG11202101789SA (en) * 2018-07-26 2021-03-30 Univ Kyoto Method for generating cells into which an exogenous antigen receptor is introduced
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
AU2020344628A1 (en) * 2019-09-12 2022-04-07 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins
WO2021113297A1 (en) 2019-12-02 2021-06-10 Regeneron Pharmaceuticals, Inc. Peptide-mhc ii protein constructs and uses thereof
AU2021244594A1 (en) * 2020-03-27 2022-12-01 Regeneron Pharmaceuticals, Inc. T cell receptors
CN113684258A (zh) * 2020-05-18 2021-11-23 上海赛比曼生物科技有限公司 用于检测鼠源tcr转基因拷贝数的试剂盒及方法
CN116981357A (zh) 2021-03-31 2023-10-31 瑞泽恩制药公司 包含具有改善的tcrb组库多样性的人源化细胞免疫***组分的基因修饰的小鼠
WO2024035962A2 (en) * 2022-08-12 2024-02-15 Ingenious Targeting Laboratories Genetically modified non-human having humanized gamma and delta tcr variable genes
WO2024064860A1 (en) 2022-09-22 2024-03-28 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing components of human cellular immune system

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0663952A4 (en) 1992-09-11 1997-06-11 Univ California TRANSGENIC NON-HUMAN ANIMALS WITH TARGETED INTERRUPTED TRANSDUCTION GENES IN LYMPHOCYTES.
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
AU728794B2 (en) 1996-03-05 2001-01-18 Scripps Research Institute, The Recombinant constructs encoding T cell receptors specific for human HLA-restricted tumor antigens
US6320306B1 (en) * 1996-08-05 2001-11-20 Samsung Display Devices Co., Ltd. Shadow mask with porous insulating layer and heavy metal layer
EP2314625B1 (en) 1996-12-03 2014-05-07 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
AU1023401A (en) 1999-10-12 2001-04-23 Institut Pasteur Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice
US7462486B2 (en) 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20050050580A1 (en) 2000-12-13 2005-03-03 Masashi Gotoh Transgenic animal expressing hla-a24 and utilization thereof
AU2002246733B2 (en) * 2000-12-19 2007-09-20 Altor Bioscience Corporation Transgenic animals comprising a humanized immune system
FR2827302B1 (fr) 2001-07-13 2003-10-10 Genoway Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
ATE290020T1 (de) 2001-08-31 2005-03-15 Avidex Ltd Löslicher t zell rezeptor
EP1452093A4 (en) 2001-11-15 2007-08-15 Kirin Brewery CHIMERIC ANIMALS
ATE279441T1 (de) * 2001-12-22 2004-10-15 4Antibody Ag Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
US7741077B2 (en) 2001-12-22 2010-06-22 4-Antibody Ag Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
DE10244457A1 (de) 2002-09-24 2004-04-01 Johannes-Gutenberg-Universität Mainz Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren
US7569664B2 (en) 2002-10-09 2009-08-04 Immunocore Limited Single chain recombinant T cell receptors
WO2004042004A2 (en) * 2002-10-30 2004-05-21 The Wistar Institute Of Anatomy And Biology Mouse model for autoimmune disorders
US7663017B2 (en) * 2003-07-30 2010-02-16 Institut Pasteur Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
PT1802193E (pt) 2004-10-19 2014-06-23 Regeneron Pharma Método para gerar um murganho homozigótico para uma modificação genética
AU2007248019B2 (en) 2006-05-03 2012-10-11 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Chimeric T cell receptors and related materials and methods of use
EP1878342A1 (en) 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
WO2008051854A2 (en) 2006-10-20 2008-05-02 Trustees Of Boston University A tunable genetic switch for regulating gene expression
JP2008159109A (ja) 2006-12-21 2008-07-10 Matsushita Electric Ind Co Ltd データ転送装置
WO2009114400A1 (en) 2008-03-07 2009-09-17 Regeneron Pharmaceuticals, Inc. Es cell-derived mice from diploid host embryo injection
US20090328240A1 (en) 2008-06-24 2009-12-31 Sing George L Genetically modified mice as predictors of immune response
WO2010107400A1 (en) * 2009-03-20 2010-09-23 Agency For Science, Technology And Research Genetically modified animal and method of obtaining the same
DK3028564T5 (da) 2009-07-08 2024-04-29 Kymab Ltd Dyremodeller og terapeutiske molekyler
GB0917090D0 (en) 2009-09-29 2009-11-11 Ucl Biomedica Plc T-cell receptor
US10464987B2 (en) 2009-10-06 2019-11-05 Abbvie Inc. Human single-chain T cell receptors
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
WO2012039779A1 (en) 2010-09-24 2012-03-29 The United States Of America As Represented By The Secretary Of The Navy Humanized transgenic mouse model
CN105950654B (zh) 2010-11-27 2020-03-20 朱坚 一种人源化的转基因动物
IL305550A (en) * 2011-10-28 2023-10-01 Regeneron Pharma Mice with a genetic change in the T cell receptor
RU2732628C2 (ru) 2015-04-06 2020-09-21 Регенерон Фармасьютикалз, Инк. Опосредованные гуманизированными т-клетками иммунные ответы у не относящихся к человеку животных

Also Published As

Publication number Publication date
KR102542272B1 (ko) 2023-06-13
MX2014004894A (es) 2014-09-12
EP3424947A1 (en) 2019-01-09
EP2771357B1 (en) 2018-07-18
PL3424947T3 (pl) 2021-06-14
IN2014CN03890A (lt) 2015-10-16
HRP20181626T1 (hr) 2018-12-14
ES2858978T3 (es) 2021-09-30
KR20140077219A (ko) 2014-06-23
AU2012327204B2 (en) 2016-01-21
DK3424947T3 (da) 2021-02-22
CN114891798A (zh) 2022-08-12
PT3424947T (pt) 2021-03-01
IL232098B (en) 2020-06-30
US11528895B2 (en) 2022-12-20
US20220386575A1 (en) 2022-12-08
JP6706311B2 (ja) 2020-06-03
JP2019033770A (ja) 2019-03-07
RU2014121160A (ru) 2015-12-10
CY1120945T1 (el) 2019-12-11
PT2771357T (pt) 2018-11-09
KR102148387B1 (ko) 2020-08-26
RS57893B1 (sr) 2019-01-31
AU2012327204A1 (en) 2013-05-23
HK1198171A1 (en) 2015-03-13
CN107858333B (zh) 2022-05-27
LT3424947T (lt) 2021-03-10
SI2771357T1 (sl) 2018-11-30
DK2771357T3 (en) 2018-10-29
KR20190037354A (ko) 2019-04-05
CY1123831T1 (el) 2022-05-27
PL2771357T3 (pl) 2018-12-31
BR112014009203B1 (pt) 2023-02-28
RU2661106C2 (ru) 2018-07-11
KR20200102001A (ko) 2020-08-28
IL305550A (en) 2023-10-01
AU2016202512B2 (en) 2018-03-29
US20130109053A1 (en) 2013-05-02
IL274914B2 (en) 2024-02-01
US20210051930A1 (en) 2021-02-25
IL232098A0 (en) 2014-05-28
IL274914A (en) 2020-07-30
EP3795587A1 (en) 2021-03-24
BR112014009203A2 (pt) 2020-10-27
KR20220066197A (ko) 2022-05-23
WO2013063361A1 (en) 2013-05-02
CN104011071A (zh) 2014-08-27
EP2771357A1 (en) 2014-09-03
AU2021203192A1 (en) 2021-06-10
IL274914B1 (en) 2023-10-01
AU2018204700B2 (en) 2021-04-01
EP3424947B1 (en) 2020-11-25
RS61455B1 (sr) 2021-03-31
SG11201401030WA (en) 2014-04-28
JP2018007696A (ja) 2018-01-18
AU2018204700A1 (en) 2018-07-19
KR101964776B1 (ko) 2019-04-04
US20160021856A1 (en) 2016-01-28
AU2016202512C1 (en) 2018-10-11
CN107858332A (zh) 2018-03-30
CN104011071B (zh) 2017-11-07
AU2018204700C1 (en) 2021-10-14
JP2014532413A (ja) 2014-12-08
JP6254528B2 (ja) 2017-12-27
KR102321909B1 (ko) 2021-11-05
SG10201914043XA (en) 2020-03-30
KR102397961B1 (ko) 2022-05-13
AU2016202512A1 (en) 2016-05-12
CN107858333A (zh) 2018-03-30
JP2020146045A (ja) 2020-09-17
JP2024019646A (ja) 2024-02-09
CN114891797A (zh) 2022-08-12
JP2023024744A (ja) 2023-02-16
ES2691475T3 (es) 2018-11-27
JP2022093637A (ja) 2022-06-23
MX353134B (es) 2017-12-20
SI3424947T1 (sl) 2021-04-30
CA2853707A1 (en) 2013-05-02
HUE053444T2 (hu) 2021-06-28
NZ623147A (en) 2016-03-31
US9113616B2 (en) 2015-08-25
JP7305840B2 (ja) 2023-07-10
JP6532924B2 (ja) 2019-06-19
AU2021203192B2 (en) 2024-04-11
HRP20210256T1 (hr) 2021-04-02
KR20210133325A (ko) 2021-11-05

Similar Documents

Publication Publication Date Title
IL274914A (en) Mice with a genetic change in the T cell receptor
IL261239A (en) Mice with genetic mhc alterations
IL260209B (en) (major histocompatibility complex) mice with genetically modified tissue compatible complex
ZA201300621B (en) T cell receptors
AU338030S (en) Solar cell
EP3719852C0 (en) SOLAR CELL
EP2717322A4 (en) SOLAR CELL
EP2690669A4 (en) SOLAR CELL
GB2489959B (en) Pyrolyser
EP2738819A4 (en) SOLAR CELL
GB201116427D0 (en) T cell receptors
GB201201418D0 (en) T Cell receptors
GB201108193D0 (en) Sugars & carbs